Proprietary AI analyst is now available

Toyo Seikan Valuation Multiples

Discover Toyo Seikan's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like SCG Packaging, Huhtamaki, Greif, Silgan Holdings and more.

Toyo Seikan Overview

About Toyo Seikan

Toyo Seikan Group Holdings Ltd is a Japan-based packaging container manufacturer. The company operates through six segments. The Engineering, Filling, and Logistics segment handles packaging equipment, contract filling, and cargo transport. The Functional Materials segment covers aluminum substrates, optical films, pigments, frit, and gelcoats. The Packaging Container segment produces metal, plastic, paper, and glass containers. The Real Estate segment focuses on leasing office buildings and commercial facilities. The Steel Plate segment manufactures and sells steel plates and related products. The Others segment includes automotive press dies, rigid combiners, and non-life insurance agency services. It generates the majority of its revenue from the Packaging container business segment.


Founded

2012

HQ

Japan

Employees

21.4K

Financials (LTM)

Revenue: $6B
Net Income: $347M

EV

$4B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Toyo Seikan Financials

Toyo Seikan reported last 12-month revenue of $6B.

In the same LTM period, Toyo Seikan generated $347M in net income.

Revenue (LTM)


Toyo Seikan P&L

In the most recent fiscal year, Toyo Seikan reported revenue of $6B and EBITDA of $580M.

Toyo Seikan is profitable as of last fiscal year, with gross margin of 13%, EBITDA margin of 10%, and net margin of 2%.

See analyst estimates for Toyo Seikan
LTMLast FY202320242025202620272028
Revenue$6B$6B$6B$6B$6B
Gross Profit-$766M$692M$760M$766M
Gross Margin-13%12%13%13%
EBITDA-$580M$544M$580M$580M
EBITDA Margin-10%9%10%10%
EBIT Margin5%4%3%4%5%
Net Profit$347M$140M$124M$141M$295M
Net Margin6%2%2%2%5%
Net Debt-$665M---

Financial data powered by Morningstar, Inc.

Toyo Seikan Stock Performance

Toyo Seikan has current market cap of $4B, and enterprise value of $4B.

Market Cap Evolution


Toyo Seikan's stock price is $23.58.

Toyo Seikan share price decreased by 3.4% in the last 30 days, and increased by 32.7% in the last year.

Toyo Seikan has an EPS (earnings per share) of $0.93.

See more trading valuation data for Toyo Seikan
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$4B$4B-0.6%-3.4%5.9%32.7%$0.93

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Toyo Seikan Valuation Multiples

Toyo Seikan trades at 0.7x EV/Revenue multiple, and 7.0x EV/EBITDA.

See NTM and 2027E valuation multiples for Toyo Seikan

EV / Revenue (LTM)


Toyo Seikan Financial Valuation Multiples

As of June 6, 2026, Toyo Seikan has market cap of $4B and EV of $4B.

Toyo Seikan has a P/E ratio of 10.2x.

LTMLast FY202320242025202620272028
EV/Revenue0.7x0.7x0.7x0.7x0.7x
EV/EBITDA-7.0x7.5x7.0x7.0x
EV/EBIT12.4x19.0x23.8x19.0x13.5x
EV/Gross Profit-5.3x5.9x5.3x5.3x
P/E10.2x25.4x28.5x25.2x12.0x
EV/FCF-10.8x(51.3x)13.6x10.8x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Toyo Seikan Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Toyo Seikan Margins & Growth Rates

Toyo Seikan grew revenue by 5% and net profit by 148% in the last fiscal year.

In the most recent fiscal year, Toyo Seikan reported gross margin of 13%, EBITDA margin of 10%, and net margin of 2%.

See estimated margins and future growth rates for Toyo Seikan

Toyo Seikan Margins

Last FY202420252026202720282029
Gross Margin13%13%13%-
EBITDA Margin10%10%10%-
EBIT Margin4%4%5%5%
Net Margin2%2%5%6%
FCF Margin6%5%6%-

Toyo Seikan Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth5%(1%)3%1%
Gross Profit Growth-10%1%-
EBITDA Growth-7%(0%)-
EBIT Growth53%25%40%10%
Net Profit Growth148%13%109%18%
FCF Growth-(477%)26%-

Data powered by FactSet, Inc. and Morningstar, Inc.

Toyo Seikan Operational KPIs

Toyo Seikan's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.0M for the same period.

Access forward-looking KPIs for Toyo Seikan
Last FY202320242025202620272028
Revenue per Employee$0.3M---
Opex per Employee$0.0M---
Opex to Revenue10%9%9%9%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Toyo Seikan Competitors

Toyo Seikan competitors include SCG Packaging, Huhtamaki, Greif, Silgan Holdings, Graphic Packaging, Vidrala, Viscofan, Verallia, Ableprint and SKC.

Most Toyo Seikan public comparables operate across Packaging & Containers.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
SCG Packaging1.2x1.2x9.3x9.1x
Huhtamaki1.0x1.0x6.4x6.5x
Greif1.1x1.0x8.2x7.2x
Silgan Holdings1.2x1.2x8.2x8.1x
Graphic Packaging1.0x1.0x6.2x6.8x
Vidrala1.8x1.8x6.1x6.0x
Viscofan2.2x2.2x9.5x9.4x
Verallia1.2x1.3x6.0x6.0x

This data is available for Pro users. Sign up to see all Toyo Seikan competitors and their valuation data.

Start Free Trial

Acquisitions by Toyo Seikan

Toyo Seikan has acquired 1 company to date.

Last acquisition by Toyo Seikan was on May 8th 2014. Toyo Seikan acquired GC Lymphotec for $2M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Toyo Seikan

GC Lymphotec
Description
GC Lymphotec is a Japanese healthcare company offering lymphatic care services for cancer patients. Based in Tokyo, it provides manual lymph drainage, compression therapy, and post-surgical rehabilitation to manage lymphedema. The firm collaborates with hospitals to support breast cancer and gynecological surgery recovery.
HQ CountryJapan
HQ City
Tokyo
Deal Date8 May 2014
Valuation$2M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Toyo Seikan acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Toyo Seikan

Toyo Seikan has invested in 6 companies to date.

Latest investment by Toyo Seikan was on March 3rd 2025. Toyo Seikan invested in Seadling in their $1M Seed round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Toyo Seikan

Seadling
Umitron
DAIZ
Cellusion
Description
Seadling is a Kuala Lumpur-headquartered biotechnology firm developing modular systems to scale seaweed cultivation for food, fuel, and carbon sequestration applications. Founded in 2018, it deploys floating farms in Southeast Asian waters using AI-optimized seeding and harvesting, partnering with regional governments for pilot projects off Malaysia and Indonesia.
Umitron delivers AI-driven data analytics for aquaculture farms, optimizing fish feeding via underwater cameras and sensors. Tokyo-headquartered Umitron serves salmon producers in Norway and Japan with eFishery platform integrations. The company deploys drone monitoring for sea cages to reduce feed waste by 20 percent.
DAIZ is a Tokyo-based food technology company producing plant-based meat alternatives under the Miracle Meat brand. It ferments germinated soybeans via the proprietary Ochiai Germination Method to create products mimicking beef, chicken, and pork in texture and flavor. DAIZ also researches soybean-derived pharmaceuticals and functional ingredients. Founded in 2020, the company sells through supermarkets in Japan and partners with restaurants for menu integration.
Cellusion is a Tokyo-headquartered regenerative medicine company originating from Keio University that engineers corneal endothelial cells from induced pluripotent stem cells to treat bullous keratopathy. Their mass culture system produces clinical-grade cells at scale, addressing a condition affecting over 100,000 patients annually in Japan alone. Cellusion advances therapies through partnerships with Japanese hospitals and holds orphan drug designation from the Ministry of Health, Labour and Welfare.
HQ CountryMalaysiaSingaporeJapanJapan
HQ City
Kota Kinabalu
Singapore
Kumamoto
Tokyo
Deal Date3 Mar 20257 Jun 20221 Feb 20226 Jan 2022
RoundSeedSeries BSeries CSeries A
Raised$1M$9M$26M$10M
InvestorsAgFunder; Katapult Ocean; KUL LOESNINGAR 3; The Yield Lab Asia Pacific; Toyo SeikanENEOS Holdings; QB Capital; Toyo SeikanGlobal Brain Corporation; Investment Lab; Marui Group; Mitsubishi Chemical Holdings Corporation; MITSUI SUMITOMO INSURANCE Venture Capital (MSIVC); Nissin Foods; Sumitomo Mitsui Trust Bank; Toyo SeikanDBJ Capital; Gemseki; Keio Innovation Initiative; SMBC Venture Capital; Toho Holdings; Toyo Seikan; UTEC-The University of Tokyo Edge Capital Partners
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Toyo Seikan investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Toyo Seikan

When was Toyo Seikan founded?Toyo Seikan was founded in 2012.
Where is Toyo Seikan headquartered?Toyo Seikan is headquartered in Japan.
How many employees does Toyo Seikan have?As of today, Toyo Seikan has over 21K employees.
Is Toyo Seikan publicly listed?Yes, Toyo Seikan is a public company listed on Tokyo Stock Exchange.
What is the stock symbol of Toyo Seikan?Toyo Seikan trades under 5901 ticker.
When did Toyo Seikan go public?Toyo Seikan went public in 1949.
Who are competitors of Toyo Seikan?Toyo Seikan main competitors include SCG Packaging, Huhtamaki, Greif, Silgan Holdings, Graphic Packaging, Vidrala, Viscofan, Verallia, Ableprint, SKC.
What is the current market cap of Toyo Seikan?Toyo Seikan's current market cap is $4B.
What is the current revenue of Toyo Seikan?Toyo Seikan's last 12 months revenue is $6B.
What is the current revenue growth of Toyo Seikan?Toyo Seikan revenue growth (vs. last FY) is 5%.
What is the current EV/Revenue multiple of Toyo Seikan?Current revenue multiple of Toyo Seikan is 0.7x.
What is the current net income of Toyo Seikan?Toyo Seikan's last 12 months net income is $347M.
How many companies Toyo Seikan has acquired to date?As of June 2026, Toyo Seikan has acquired 1 company.
What was the largest acquisition by Toyo Seikan?$2M acquisition of GC Lymphotec on 8th May 2014 was the largest M&A Toyo Seikan has done to date.
What companies Toyo Seikan acquired?Toyo Seikan acquired GC Lymphotec.
In how many companies Toyo Seikan has invested to date?As of June 2026, Toyo Seikan has invested in 6 companies.
What was the last Toyo Seikan investment?On 3rd March 2025 Toyo Seikan invested in Seadling, participating in a $1M Seed round, alongside AgFunder, Katapult Ocean, KUL LOESNINGAR 3, and The Yield Lab Asia Pacific.
In what companies Toyo Seikan invested in?Toyo Seikan invested in DAIZ, Shiok Meats, Cellusion, Umitron, Seadling, and IPS Portal.

See public comps similar to Toyo Seikan

Lists including Toyo Seikan

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial